Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
US8008449 | NA | Human monoclonal antibodies to programmed death 1 (PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics |
Mar, 2020
(4 years ago) |
Ingredients: NIVOLUMAB